This study is a 21-day supervised in-use test with 20 volunteers representing all skin types, conducted under the oversight of a qualified dermatologist. The study includes clinical evaluation and final dermatological sign-off, providing medically supervised data on product tolerance and performance under real-use conditions.
Because many cosmetic and personal care products are intended for repeated skin contact, this study helps evaluate how products perform over time while ensuring clinical oversight.
This study evaluates how a product performs when used on the skin under normal conditions. It focuses on:
It also helps determine whether repeated use may lead to irritation or adverse skin reactions.
The study follows a controlled, supervised in-use design over 21 days at a clinical site.
This approach ensures that results reflect real-world product use while maintaining clinical rigor.
Participants are selected to represent a range of skin types based on the intended product use.
All participants:
This ensures that observed effects are attributable to the product rather than unrelated factors.
Clinical and subjective evaluations are conducted throughout the study.
Clinical assessments may include:
Participants also complete structured questionnaires to assess:
Both clinical observations and user feedback are included in the final evaluation.
This study can support a range of marketing and safety claims, including:
Final claim support depends on study outcomes and applicable regulatory guidance.
At the conclusion of the study:
The report is suitable for use in safety documentation, regulatory submissions, and marketing support.
Pentyl Labs coordinates supervised in-use testing with:
We also support related services such as HRIPT, safety assessments, and claims substantiation, allowing results to fit seamlessly into your product development and compliance strategy.
Contact [email protected] to request a Supervised In-Use Test under Dermatological Control.